Page last updated: 2024-11-06

fluorescamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Fluorescamine is a highly sensitive fluorogenic reagent used to detect primary amines. It is a non-fluorescent compound until it reacts with primary amines to produce a highly fluorescent derivative. This reaction is highly specific and sensitive, making fluorescamine a valuable tool in various fields, including biochemistry, analytical chemistry, and clinical diagnostics. Its synthesis involves a multi-step process starting with the condensation of 4-aminophthalic acid with formaldehyde. Fluorescamine reacts with primary amines to form a highly fluorescent derivative that can be detected by fluorometry. The intensity of fluorescence is proportional to the concentration of the primary amine. This property has led to the widespread use of fluorescamine in various applications, including amino acid analysis, protein quantification, and detection of primary amines in biological samples. Fluorescamine is also used in immunofluorescence staining, where it reacts with primary antibodies to visualize the location of specific proteins in cells or tissues. Its ability to detect primary amines makes it an important tool in studying protein structure, function, and interactions. The unique properties of fluorescamine, particularly its high sensitivity and selectivity for primary amines, continue to drive its use in research and diagnostics. The compound's potential to detect minute amounts of primary amines opens up avenues for developing novel analytical techniques and diagnostic assays in various fields.'

Fluorescamine: A nonfluorescent reagent for the detection of primary amines, peptides and proteins. The reaction products are highly fluorescent. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID37927
SCHEMBL ID37303
MeSH IDM0008598

Synonyms (37)

Synonym
spiro[furan-2(3h),1'(3'h)-isobenzofuran]-3,3'-dione, 4-phenyl-
fluorescamine
zfkjvjidpqddfy-uhfffaoysa-
inchi=1/c17h10o4/c18-15-13(11-6-2-1-3-7-11)10-20-17(15)14-9-5-4-8-12(14)16(19)21-17/h1-10h
4'-phenylspiro[2-benzofuran-3,2'-furan]-1,3'-dione
38183-12-9
AKOS000813784
F0192
4-phenylspiro[furan-2(3h),1'-phthalan]-3,3'-dione
4'-phenylspiro[2-benzofuran-3,2'-furan]-1,3'-dion
4-phenylspiro(furan-2(3h),1'(3'h)-isobenzofuran)-3,3'-dione
unii-y6859v58yw
y6859v58yw ,
spiro(furan-2(3h),1'(3'h)-isobenzofuran)-3,3'-dione, 4-phenyl-
einecs 253-814-5
fluram
BP-13091
FT-0626448
4-phenylspiro[furan-2(3h),1-phthalan]-3,3'-dione
SCHEMBL37303
CS-3522
W-202560
4-phenylspiro(furan-2(3h),1'-phthalan)-3,3'-dione
fluorescamine [mi]
ro-20-7234
HY-D0715
4-phenylspiro-[furan-2(3h),1-phthalan]-3,3'-dione
mfcd00005928
fluram, bioreagent, suitable for fluorescence, >=99.0% (uv)
fluorescamine, >=98.0%
4-phenyl-3h,3'h-spiro[furan-2,1'-isobenzofuran]-3,3'-dione ,
Q238913
AS-14756
ro 20-7234
DTXSID50872017
4'-phenyl-3h,3'h-spiro[2-benzofuran-1,2'-furan]-3,3'-dione
EN300-302799

Research Excerpts

Overview

Fluorescamine is a nonfluorescent substance that reacts with primary amines to yield intensely fluorescent products. It was not found to be a specific reagent for the cell surface.

ExcerptReferenceRelevance
"Fluorescamine is a sensitive cytochemical probe for primary amino groups and produces an intense general fluorescence in unfixed tissue sections reflecting the ubiquitous occurrence of such groups. "( Formaldehyde-fluorescamine-induced fluorescence as a property of carcinoma cells.
Ingemansson, S; Larsson, LI; Mørch-Jørgensen, L, 1979
)
2.07
"Fluorescamine is a versatile reagent for the cytochemical demonstration of primary amino groups. "( Fluorescamine as a cytochemical detection reagent for mammary carcinoma cells.
Larsson, LI; Sundler, F; Uddman, R,
)
3.02
"Fluorescamine is a nonfluorescent substance that reacts with primary amines to yield intensely fluorescent products. "( An analyst in biomedical research.
Udenfriend, S, 1979
)
1.7
"Fluorescamine was not found to be a specific reagent for the cell surface."( Labeling of membranes from erythrocytes and corn with fluorescamine.
Briggs, WR; Cross, JW, 1977
)
1.23
"Fluorescamine is a useful fluorescence microscopic reagent for the demonstration of certain peptide hormone-secreting cells in formaldehyde-fixed tissues. "( Fluorescamine as a histochemical reagent: demonstration of polypeptide hormone-secreting cells.
Håkanson, R; Larsson, LI; Sundler, F, 1975
)
3.14

Effects

ExcerptReferenceRelevance
"Fluorescamine has been used for labelling proteins present on the surface of normal human peripheral blood lymphocytes. "( Fluorescent labelling of proteins of lymphocyte plasma membranes.
Fessas, P; Lambris, J; Papamichail, M, 1979
)
1.7

Actions

ExcerptReferenceRelevance
"The fluorescamine method had a lower detection limit compared with the other methods, whereas gel electrophoresis was the best qualitative method for monitoring β-casein proteolysis products."( Comparison of methods for analysis of proteolysis by plasmin in milk.
Chove, LM; Grandison, AS; Lewis, MJ, 2011
)
0.85

Treatment

ExcerptReferenceRelevance
"In fluorescamine-treated sarcoplasmic reticulum the vanadate-induced crystals contain significant P1-type regions in addition to the dominant P2 form."( Effect of chemical modification on the crystallization of Ca2+-ATPase in sarcoplasmic reticulum.
Csermely, P; Dux, L; Martonosi, A; Mullner, N; Varga, S, 1987
)
0.79

Bioavailability

ExcerptReferenceRelevance
" Insulin conjugated to transferrin by forming disulfide bonds has been shown to improve insulin oral bioavailability in diabetic rats."( Synthesis and characterization of insulin-transferrin conjugates.
Brodbelt, JS; Kavimandan, NJ; Losi, E; Peppas, NA; Wilson, JJ,
)
0.13

Dosage Studied

Fluorescamine is a fast reacting NH2-group-specific reagent. The method was developed and validated for the evaluation of pregabalin in a pharmaceutical dosage form.

ExcerptRelevanceReference
" The method was successfully applied to commercially available dosage forms."( Rapid fluorometric determination of procainamide hydrochloride dosage forms.
Beiser, C; TTan, HS, 1975
)
0.25
" A semilogarithmic plot of the dose-response curve revealed three different pools of phosphatidylethanolamine, representing its fractions in, respectively, the inner- and outer monolayers of the plasma membrane and subcellular membrane systems."( The transbilayer distribution of phosphatidylethanolamine in erythroid plasma membranes during erythropoiesis.
Nijhof, W; Op den Kamp, JA; Roelofsen, B; van Deenen, LL; van der Schaft, PH; Wierenga, PK, 1986
)
0.27
" Contrastingly, dose-response curves recorded for the labeling of PE with the very fast reacting NH2-group-specific reagent, fluorescamine, showed identical results for both native and diamide-treated erythrocytes."( Does diamide treatment of intact human erythrocytes cause a loss of phospholipid asymmetry?
Franck, PF; Op den Kamp, JA; Roelofsen, B; van Deenen, LL, 1986
)
0.48
" The proposed methods were successfully applied for the analysis of MTX in pure drug and tablets dosage form."( Study of stability of methotrexate in acidic solution spectrofluorimetric determination of methotrexate in pharmaceutical preparations through acid-catalyzed degradation reaction.
Abdel-Hady, M; Elsayed, M; Fahmy, OT; Maher, HM; Sabry, SM, 2003
)
0.32
"1%, indicating that no interference is observed from concomitants usually present in dosage forms."( A spectrofluorimetric sequential injection method for the determination of penicillamine using fluorescamine in the presence of beta-cyclodextrins.
Al-Kindy, SM; Al-Lawati, ZH; Suliman, FE, 2008
)
0.56
"A simple, fast, and sensitive HPLC method was developed and validated for the evaluation of pregabalin in a pharmaceutical dosage form using fluorescamine as a derivatization agent for the first time."( Rapid high-performance liquid chromatography method for determination of pregabalin in a pharmaceutical dosage form following derivatization with fluorescamine.
Grabnar, I; Martinc, B; Mrhar, A; Vovk, T,
)
0.53
"A new, simple and sensitive spectrofluorimetric method has been developed for the determination of aliskiren (ALS) in dosage forms and human urine."( Spectrofluorimetric determination of aliskiren in dosage forms and urine.
Aydoğmuş, Z,
)
0.13
"64%, indicating that no interference was observed from concomitants usually present in pharmaceutical dosage forms."( Spectrofluorimetric determination of tobramycin in human serum and pharmaceutical preparations by derivatization with fluorescamine.
Önal, A; Sağırlı, AO; Tekkeli, SE, 2014
)
0.61
" Several derivatization methods have been developed and used for their determination in bulk or pharmaceutical dosage forms."( A simple high-throughput method for determination of antiepileptic analogues of γ-aminobutyric acid in pharmaceutical dosage forms using microplate fluorescence reader.
Martinc, B; Vovk, T, 2013
)
0.39
" This experiment is very simple, sensitive and selective method for determination of tranexamic acid in pure form, pharmaceutical dosage forms and in spiked human plasma."( Derivatization of tranexamic acid for its rapid spectrofluorimetric determination in pure form and pharmaceutical formulations: Application in human plasma.
Anwer, EF; Nour El-Deen, DAM; Omar, MA, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (480)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990293 (61.04)18.7374
1990's73 (15.21)18.2507
2000's64 (13.33)29.6817
2010's38 (7.92)24.3611
2020's12 (2.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.78 (24.57)
Research Supply Index6.24 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index59.29 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.20%)5.53%
Reviews6 (1.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other504 (98.63%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]